About: covid:63338806606553f16a50d919c499535af10b595f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:63338806606553f16a50d919c499535af10b595f Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Grimwood, Keith Champion, Anita Goyal, Vikas Petsky, Helen Binks, Michael Chang, Anne Mccallum, Gabrielle Morris, Peter Torzillo, Paul Ware, Robert Buntain, Helen Byrnes, Catherine Marchant, Julie Masters, Brent O'grady, Kerry-Ann Van Asperen, Peter
is schema:about of	named entity 'AZITHROMYCIN' named entity 'BRONCHIECTASIS' named entity 'DOUBLE' named entity 'BACKGROUND' named entity 'ACUTE EXACERBATIONS' named entity 'INVOLVING' named entity 'PRESCRIBED' named entity 'ORAL' named entity 'BRONCHIECTASIS' named entity 'CHILDREN' named entity 'RECOMMENDED' named entity 'LINE' named entity 'ONCE-DAILY DOSING' named entity 'CHILDREN' named entity 'RESPIRATORY' named entity 'RANDOMISED CONTROLLED TRIALS' covid:arg/63338806606553f16a50d919c499535af10b595f named entity 'KNOWLEDGE' named entity 'ANTIBIOTIC TREATMENT' named entity 'BLIND' named entity 'AMOXICILLIN-CLAVULANATE' named entity 'AZITHROMYCIN' named entity 'AMOXICILLIN-CLAVULANATE' named entity 'INFERIOR' named entity 'PUBLISHED' named entity 'NON-' named entity 'OUR' named entity 'CONVENIENT' named entity 'HAVE' named entity 'RESOLVING' named entity 'SEVERE' named entity 'RANDOMISED CONTROLLED TRIAL' named entity 'EMPIRICAL' named entity 'NON-INFERIORITY' named entity 'ITS' named entity 'amoxicillin-clavulanate' named entity 'azithromycin' named entity 'amoxicillin-clavulanate' named entity 'Amoxicillin-clavulanate' named entity 'bronchiectasis' named entity 'double-blind' named entity 'randomised controlled trial' named entity 'bronchiectasis' named entity 'randomised controlled trials' named entity 'bronchiectasis' named entity 'azithromycin' named entity 'bronchiectasis' named entity 'acute exacerbations' named entity 'first-line' named entity 'antibiotic treatment' named entity 'azithromycin' nodeID://b56169454 nodeID://b56174098 nodeID://b56176838 nodeID://b56187398 nodeID://b56196198 nodeID://b56203450 nodeID://b56208886 nodeID://b56224846 nodeID://b56236250 nodeID://b56254966 nodeID://b56277098 nodeID://b56290094 nodeID://b56298582 nodeID://b56303334 nodeID://b56330954 nodeID://b56337490 nodeID://b56342754 nodeID://b56346622 nodeID://b56360754 nodeID://b56395490 nodeID://b56397014 nodeID://b56568378 nodeID://b56575502 nodeID://b56753018 nodeID://b56789414 nodeID://b56920666 nodeID://b56982898 nodeID://b57047762 nodeID://b57146026 nodeID://b57328778 nodeID://b57544370 nodeID://b57772966 nodeID://b58111282

Attributes

Values

Creator

Grimwood, Keith
Champion, Anita
Goyal, Vikas
Petsky, Helen
Binks, Michael
Chang, Anne
Mccallum, Gabrielle
Morris, Peter
Torzillo, Paul
Ware, Robert
Buntain, Helen
Byrnes, Catherine
Marchant, Julie
Masters, Brent
O'grady, Kerry-Ann
Van Asperen, Peter

is schema:about of

named entity 'AZITHROMYCIN'
named entity 'BRONCHIECTASIS'
named entity 'DOUBLE'
named entity 'BACKGROUND'
named entity 'ACUTE EXACERBATIONS'
named entity 'INVOLVING'
named entity 'PRESCRIBED'
named entity 'ORAL'
named entity 'BRONCHIECTASIS'
named entity 'CHILDREN'
named entity 'RECOMMENDED'
named entity 'LINE'
named entity 'ONCE-DAILY DOSING'
named entity 'CHILDREN'
named entity 'RESPIRATORY'
named entity 'RANDOMISED CONTROLLED TRIALS'
covid:arg/63338806606553f16a50d919c499535af10b595f
named entity 'KNOWLEDGE'
named entity 'ANTIBIOTIC TREATMENT'
named entity 'BLIND'
named entity 'AMOXICILLIN-CLAVULANATE'
named entity 'AZITHROMYCIN'
named entity 'AMOXICILLIN-CLAVULANATE'
named entity 'INFERIOR'
named entity 'PUBLISHED'
named entity 'NON-'
named entity 'OUR'
named entity 'CONVENIENT'
named entity 'HAVE'
named entity 'RESOLVING'
named entity 'SEVERE'
named entity 'RANDOMISED CONTROLLED TRIAL'
named entity 'EMPIRICAL'
named entity 'NON-INFERIORITY'
named entity 'ITS'
named entity 'amoxicillin-clavulanate'
named entity 'azithromycin'
named entity 'amoxicillin-clavulanate'
named entity 'Amoxicillin-clavulanate'
named entity 'bronchiectasis'
named entity 'double-blind'
named entity 'randomised controlled trial'
named entity 'bronchiectasis'
named entity 'randomised controlled trials'
named entity 'bronchiectasis'
named entity 'azithromycin'
named entity 'bronchiectasis'
named entity 'acute exacerbations'
named entity 'first-line'
named entity 'antibiotic treatment'
named entity 'azithromycin'
nodeID://b56169454
nodeID://b56174098
nodeID://b56176838
nodeID://b56187398
nodeID://b56196198
nodeID://b56203450
nodeID://b56208886
nodeID://b56224846
nodeID://b56236250
nodeID://b56254966
nodeID://b56277098
nodeID://b56290094
nodeID://b56298582
nodeID://b56303334
nodeID://b56330954
nodeID://b56337490
nodeID://b56342754
nodeID://b56346622
nodeID://b56360754
nodeID://b56395490
nodeID://b56397014
nodeID://b56568378
nodeID://b56575502
nodeID://b56753018
nodeID://b56789414
nodeID://b56920666
nodeID://b56982898
nodeID://b57047762
nodeID://b57146026
nodeID://b57328778
nodeID://b57544370
nodeID://b57772966
nodeID://b58111282

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software